Platelet Rich Plasma Market Forecasts to 2028 | Drivers and Opportunities| Key player Analysis AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies

According to Stratistics MRC, the Global Platelet Rich Plasma market is accounted for $476.10 million in 2020 and is expected to reach $1,358.12 million by 2028 growing at a CAGR 14.0% during the forecast period. The rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areas and increase in the number of orthopaedic surgeries & sports injuries are the major factors driving the market growth. However, high cost of the treatment is restraining the market growth.

Request for a Free Sample Copy of Report at

Based on product type, the leukocyte rich platelet rich plasma (L-PRP) segment is estimated to have a lucrative growth, due to the potential risks associated with leukocyte rich PRP, this market space is witnessing a significant increase in the commercial pool and number of experimental systems and expanding potential applications across orthopedic, general surgery, and sports medicine. By geography, North America is going to have high growth during forecast period due to rising incidence of orthopedic diseases, rise in demand for cosmetic surgeries along with the approvals of various products by the U.S. FDA and growing awareness amongst the patient population in this particular region.

Some of the key players profiled in the Platelet Rich Plasma Market include AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, Glofinn Oy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, Arthrex Inc, Stryker Exactech Inc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC, Zimmer Biomet Company.

Products Covered:
• Instruments
• Leukocyte Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
• Platelet Rich Plasma (PRP) Gel
• Pure Platelet Rich Plasma (P-PRP)
• Pure Platelet-Rich Fibrin (P-PRF)

Source /Origin Covered:
• Autologous
• Allogeneic
• Homologous

Applications Covered:
• Sports Medicine
• Cosmetic Surgery and Dermatology
• Orthopedic/Spinal Surgery
• Dermatology
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Dentistry
• Cardiac Muscle Injury
• Nerve Injury
• Periodontal Surgery
• Aesthetics
• Other Applications

Growth Factor Molecules Covered:
• Platelet-Derived Growth Factor (PDGF)
• Vascular Endothelial Growth Factor (VEGF)
• Epidermal Growth Factor (EGF)
• Fibroblast Growth Factor-2 (FGF-2)
• Insulin-like Growth Factor (IGF)

End Users Covered:
• Hospitals & Clinics 
• Academic & Research Institutes 
• Orthopedic Clinics
• Cosmetic/Dermatology/Trichology Clinics
• Physician’s office/Private Practice
• Ophthalmic Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

If Any Query? Ask Our Industry Expert at

Explore the list of attractive markets during this time of Pandemic @

About Us:

StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.

Contact Us:

Stratistics Market Research Consulting

Phone: +1-301-202-5929




Request Sample